Efficacy, Safety and Biomarker Data from SCarlet RoAD—a Global Phase 3 Study of Gantenerumab in Patients with Prodromal AD
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI